News
Friday, August 22, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp.
AbbVie’s oncology segment generated combined revenues of $3.3 billion in the first half of 2025, rising 4.2% year over year ...
While this new treatment offers a vital lifeline, experts are simultaneously stressing the critical importance of recognising ...
"Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn't significantly changed since ...
Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results